logo
Plus   Neg
Share
Email

IL&FS Transportation Networks Inaugurates "Khadamat"

IL&FS Transportation Networks Ltd. has inaugurated the Sharjah General Services Company (Khadamat), in partnership with Sheikh Sultan bin Ahmed Al Qassimi, Chairman of Sharjah Media Centre. Khadamat is aimed at comprehensive and integrated development of the region through enhancing infrastructure for both the public and private sectors.

Khadamat was incorporated for managing and operating facilities; creating an international infrastructure for surface transportation, logistics, industries and services sectors; and managing such as infrastructure in accordance with international standards, including the establishment of an internal and external road network and the launch of strategic real estate development and redevelopment projects.

The Chairman of Khadamat said the company's projects, which would be implemented using the world's most advanced methods and technologies, would contribute to the stimulation of economic growth and realization of Sharjah's vision in terms of enhancing the relationship with reputable investment companies, improving economic efficiency and attracting investments.

At the BSE, IL&FS Transportation Networks shares are currently trading at Rs.112, up 0.67 percent from the previous close.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT